Aberrantly glycosylated IgA1 as a factor in the pathogenesis of IgA nephropathy

Clinical and Developmental Immunology

Volumn 2011, Issue , 2011, Pages

  Seki, George ^a   Tanaka, Mototsugu ^a   Someya, Tomonosuke ^b   Nagata, Michio ^c   Fujita, Toshiro ^a  

^a UNIVERSITY OF TOKYO   (Japan)

^b JUNTENDO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^c UNIVERSITY OF TSUKUBA   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKINE; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; GALACTOSAMINE; GALACTOSE; GLYCOSYLTRANSFERASE; IMMUNOGLOBULIN A1; IMMUNOGLOBULIN A2; INTERLEUKIN 6; METHYLPREDNISOLONE; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; N ACETYLGALACTOSAMINE; PREDNISONE; SERINE; THREONINE; TRANSFORMING GROWTH FACTOR BETA1; URIDINE DIPHOSPHATE; IMMUNOGLOBULIN A; IMMUNOSUPPRESSIVE AGENT;

ANTIGEN ANTIBODY COMPLEX; BLOOD PRESSURE REGULATION; CHROMOSOME 2Q; HAEMOPHILUS INFLUENZAE; HAPLOTYPE; HUMAN; IMMUNE RESPONSE; IMMUNOGLOBULIN A DEFICIENCY; IMMUNOGLOBULIN A NEPHROPATHY; IMMUNOGLOBULIN DEPOSITION; IMMUNOPATHOGENESIS; IMMUNOSUPPRESSIVE TREATMENT; KIDNEY FUNCTION; KIDNEY TRANSPLANTATION; NONHUMAN; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL (TOPIC); REVIEW; ANIMAL; GLYCOSYLATION; IMMUNOLOGY; PATHOLOGY;

ANIMALS; GLOMERULONEPHRITIS, IGA; GLYCOSYLATION; HUMANS; IMMUNOGLOBULIN A; IMMUNOSUPPRESSIVE AGENTS;

EID: 79953292210     PISSN: 17402522     EISSN: 17402530     Source Type: Journal    
DOI: 10.1155/2011/470803     Document Type: Review

References (63)

1. Berger J., Hinglais N., Les depots intercapillaires dIgA-IgG Journal d'Urologie et de Nephrology 1968 74 9 694 695
2. D'Amico G., The commonest glomerulonephritis in the world: IgA nephropathy Quarterly Journal of Medicine 1987 64 245 709 727 (Pubitemid 18047151)
3. Galla J. H., Iga nephropathy Kidney International 1995 47 2 377 387
4. D'Amico G., Colasanti G., Barbiano di Belgioioso G., Fellin G., Ragni A., Egidi F., Radaelli L., Fogazzi G., Ponticelli C., Minetti L., Long-term follow-up of IgA mesangial nephropathy: clinico-histological study in 374 patients Seminars in Nephrology 1987 7 4 355 358
5. Radford M. G., Donadio J. V., Bergstralh E. J., Grande J. P., Predicting renal outcome in IgA nephropathy Journal of the American Society of Nephrology 1997 8 2 199 207 (Pubitemid 127455874)
6. Ibels L. S., Gyory A. Z., IgA nephropathy: analysis of the natural history, important factors in the progression of renal disease, and a review of the literature Medicine 1994 73 2 79 102 (Pubitemid 24114627)
7. Hogg R. J., Silva F. G., Wyatt R. J., Reisch J. S., Argyle J. C., Savino D. A., Prognostic indicators in children with IgA nephropathyreport of the Southwest Pediatric Nephrology study group Pediatric Nephrology 1994 8 1 15 20 (Pubitemid 24042359)
8. Jennette J. C., Wall S. D., Wilkman A. S., Low incidence of IgA nephropathy in Blacks Kidney International 1985 28 6 944 950 (Pubitemid 16148398)
9. Seedat Y. K., Nathoo B. C., Parag K. B., Naiker I. P., Ramsaroop R., IgA nephropathy in blacks and Indians of Natal Nephron 1988 50 2 137 141
10. Donadio J. V., Grande J. P., IgA nephropathy New England Journal of Medicine 2002 347 10 738 748 (Pubitemid 35203906)
11. Allen A. C., Bailey E. M., Brenchley P. E. C., Buck K. S., Barratt J., Feehally J., Mesangial Iga1 in IgA nephropathy exhibits aberrant O-glycosylation: observations in three patients Kidney International 2001 60 3 969 973 (Pubitemid 34205796)
12. Hiki Y., Odani H., Takahashi M., Yasuda Y., Nishimoto A., Iwase H., Shinzato T., Kobayashi Y., Maeda K., Mass spectrometry proves under-O-glycosylation of glomerular IgA1 in IgA nephropathy Kidney International 2001 59 3 1077 1085 (Pubitemid 32206870)
13. Novak J., Tomana M., Matousovic K., Brown R., Hall S., Novak L., Julian B. A., Wyatt R. J., Mestecky J., IgA1-containing immune complexes in IgA nephropathy differentially affect proliferation of mesangial cells Kidney International 2005 67 2 504 513 (Pubitemid 40139842)
14. Narita I., Gejyo F., Pathogenetic significance of aberrant glycosylation of IgA1 in IgA nephropathy Clinical and Experimental Nephrology 2008 12 5 332 338
15. Allen A. C., Willis F. R., Beattie T. J., Feehally J., Abnormal IgA glycosylation in Henoch-Schonlein purpura restricted to patients with clinical nephritis Nephrology Dialysis Transplantation 1998 13 4 930 934 (Pubitemid 28161766)
16. Levinsky R. J., Barratt T. M., IgA immune complexes in Henoch-Schonlein purpura Lancet 1979 2 8152 1100 1103 (Pubitemid 10211491)
17. Raska M., Moldoveanu Z., Suzuki H., Brown R., Kulhavy R., Andrasi J., Hall S., Vu H. L., Carlsson F., Lindahl G., Tomana M., Julian B. A., Wyatt R. J., Mestecky J., Novak J., Identification and characterization of CMP-NeuAc:GalNAc-IgA1 2,6-sialyltransferase in IgA1-producing cells Journal of Molecular Biology 2007 369 1 69 78 (Pubitemid 46635435)
18. Smith A., Molyneux K., Feehally J., Barratt J., Is sialylation of IgA the agent provocateur of IgA nephropathy? Nephrology Dialysis Transplantation 2008 23 7 2176 2178 (Pubitemid 351957639)
19. Galla J. H., Iga nephropathy Kidney International 1995 47 2 377 387
20. Layward L., Allen A. C., Hattersley J. M., Harper S. J., Feehally J., Elevation of IgA in IgA nephropathy is localized in the serum and not saliva and is restricted to the IgA1 subclass Nephrology Dialysis Transplantation 1993 8 1 25 28 (Pubitemid 23050592)
21. Van Der Helm-Van Mil A. H. M., Smith A. C., Pouria S., Tarelli E., Brunskill N. J., Eikenboom H. C. J., Immunoglobulin A multiple myeloma presenting with Henoch-Schnlein purpura associated with reduced sialylation of IgA1 British Journal of Haematology 2003 122 6 915 917 (Pubitemid 37174611)
22. Zickerman A. M., Allen A. C., Talwar V., Olczak S. A., Brownlee A., Holland M., Furness P. N., Brunskill N. J., Feehally J., IgA myeloma presenting as Henoch-Schnlein purpura with nephritis American Journal of Kidney Diseases 2000 36 3 E19
23. Iwasaki H., Zhang Y., Tachibana K., Gotoh M., Kikuchi N., Kwon Y. D., Togayachi A., Kudo T., Kubota T., Narimatsu H., Initiation of O-glycan synthesis in IgA1 hinge region is determined by a single enzyme, UDP-N-acetyl- -D-galactosamine: polypeptide N-acetylgalactosaminyltransferase 2 Journal of Biological Chemistry 2003 278 8 5613 5621 (Pubitemid 36800803)
24. Ju T., Brewer K., Souza A. D., Cummings R. D., Canfield W. M., Cloning and expression of human core 1 1,3-galactosyltransferase Journal of Biological Chemistry 2002 277 1 178 186 (Pubitemid 34952043)
25. Ju T., Cummings R. D., A unique molecular chaperone cosmc required for activity of the mammalian core 1 -galactosyltransferase Proceedings of the National Academy of Sciences of the United States of America 2002 99 26 16613 16618 (Pubitemid 36034021)
26. Ju T., Cummings R. D., Protein glycosylation: chaperone mutation in Tn syndrome Nature. 2005 437 7063 1252 (Pubitemid 41568663)
27. Suzuki H., Moldoveanu Z., Hall S., Brown R., Vu H. L., Novak L., Julian B. A., Tomana M., Wyatt R. J., Edberg J. C., Alarcn G. S., Kimberly R. P., Tomino Y., Mestecky J., Novak J., IgA1-secreting cell lines from patients with IgA nephropathy produce aberrantly glycosylated IgA1 Journal of Clinical Investigation 2008 118 2 629 639 (Pubitemid 351206552)
28. Zhu L., Tang W., Li G., Lv J., Ding J., Yu L., Zhao M., Li Y., Zhang X., Shen Y., Zhang H., Wang H., Interaction between variants of two glycosyltransferase genes in IgA nephropathy Kidney International 2009 76 2 190 198
29. Gharavi A. G., Yan Y., Scolari F., Schena F. P., Frasca G. M., Ghiggeri G. M., Cooper K., Amoroso A., Viola B. F., Battini G., Caridi G., Canova C., Farhi A., Subramanian V., Nelson-Williams C., Woodford S., Julian B. A., Wyatt R. J., Lifton R. P., IgA nephropathy, the most common cause of glomerulonephritis, is linked to 6q22-23 Nature Genetics 2000 26 3 354 357
30. Paterson A. D., Liu X. Q., Wang K., Magistroni R., Song X., Kappel J., Klassen J., Cattran D., George-Hyslop P. ST., Pei Y., Genome-wide linkage scan of a large family with IgA nephropathy localizes a novel susceptibility locus to chromosome 2q36 Journal of the American Society of Nephrology 2007 18 8 2408 2415 (Pubitemid 47203857)
31. Gharavi A. G., Moldoveanu Z., Wyatt R. J., Barker C. V., Woodford S. Y., Lifton R. P., Mestecky J., Novak J., Julian B. A., Aberrant IgA1 glycosylation is inherited in familial and sporadic IgA nephropathy Journal of the American Society of Nephrology 2008 19 5 1008 1014
32. Tomana M., Matousovic K., Julian B. A., Radl J., Konecny K., Mestecky J., Galactose-deficient IgA1 in sera of IgA nephropathy patients is present in complexes with IgG Kidney International 1997 52 2 509 516 (Pubitemid 27359597)
33. Tomana M., Novak J., Julian B. A., Matousovic K., Konecny K., Mestecky J., Circulating immune complexes in IgA nephropathy consist of IgA1 with galactose-deficient hinge region and antiglycan antibodies Journal of Clinical Investigation 1999 104 1 73 81 (Pubitemid 29534347)
34. Mestecky J., Hashim O. H., Tomana M., Alterations in the IgA carbohydrate chains influence the cellular distribution of IgA1 Contributions to nephrology 1995 111 66 71
35. Ruef C., Budde K., Lacy J., Northemann W., Baumann M., Sterzel R. B., Coleman D. L., Interleukin 6 is an autocrine growth factor for mesangial cells Kidney International 1990 38 2 249 257 (Pubitemid 20324984)
36. Taniguchi Y., Yorioka N., Oda H., Yamakido M., Platelet-derived growth factor, interleukin (IL)-1, IL-6, IL-6R and tumor necrosis factor- in IgA nephropathy. An immunohistochemical study Nephron 1996 74 4 652 660 (Pubitemid 26396180)
37. Grande J. P., Role of transforming growth factor- in tissue injury and repair Proceedings of the Society for Experimental Biology and Medicine 1997 214 1 27 40
38. Yoshioka K., Takemura T., Murakami K., Okada M., Hino S., Miyamoto H., Maki S., Transforming growth factor- protein and mRNA in glomeruli in normal and diseased human kidneys Laboratory Investigation 1993 68 2 154 163 (Pubitemid 23084288)
39. Taniguchi Y., Yorioka N., Masaki T., Asakimori Y., Yamashita K., Yamakido M., Localization of transforming growth factors 1 and 2 and epidermal growth factor in IgA nephropathy Scandinavian Journal of Urology and Nephrology 1999 33 4 243 247 (Pubitemid 29439090)
40. Niemir Z. I., Stein H., Noronha I. L., Kruger C., Andrassy K., Ritz E., Walherr R., PDGF and TGF- contribute to the natural course of human IgA glomerulonephritis Kidney International 1995 48 5 1530 1541
41. Suzuki H., Fan R., Zhang Z., Brown R., Hall S., Julian B. A., Chatham W. W., Suzuki Y., Wyatt R. J., Moldoveanu Z., Lee J. Y., Robinson J., Tomana M., Tomino Y., Mestecky J., Novak J., Aberrantly glycosylated IgA1 in IgA nephropathy patients is recognized by IgG antibodies with restricted heterogeneity Journal of Clinical Investigation 2009 119 6 1668 1677
42. Moldoveanu Z., Wyatt R. J., Lee J. Y., Tomana M., Julian B. A., Mestecky J., Huang W. Q., Anreddy S. R., Hall S., Hastings M. C., Lau K. K., Cook W. J., Novak J., Patients with IgA nephropathy have increased serum galactose-deficient IgA1 levels Kidney International 2007 71 11 1148 1154 (Pubitemid 46809135)
43. Hastings M. C., Moldoveanu Z., Julian B. A., Novak J., Sanders J. T., McGlothan K. R., Gharavi A. G., Wyatt R. J., Galactose-deficient IgA1 in African Americans with IgA nephropathy: serum levels and heritability Clinical Journal of the American Society of Nephrology 2010 5 11 2069 2074
44. Pozzi C., Bolasco P., Fogazzi G., Andrulli S., Altieri P., Ponticelli C., Locatelli F., Corticosteroids in IgA nephropathy: a randomised controlled trial Lancet 1999 353 9156 883 887 (Pubitemid 29126876)
45. Pozzi C., Andrulli S., Del Vecchio L., Melis P., Fogazzi G. B., Altieri P., Ponticelli C., Locatelli F., Corticosteroid effectiveness in IgA nephropathy: long-term results of a randomized, controlled trial Journal of the American Society of Nephrology 2004 15 1 157 163 (Pubitemid 38020707)
46. Praga M., Gutirrez E., Gonzlez E., Morales E., Hernandez E., Treatment of IgA nephropathy with ace inhibitors: a randomized and controlled trial Journal of the American Society of Nephrology 2003 14 6 1578 1583 (Pubitemid 36687059)
47. Manno C., Torres D. D., Rossini M., Pesce F., Schena F. P., Randomized controlled clinical trial of corticosteroids plus ACE-inhibitors with long-term follow-up in proteinuric IgA nephropathy Nephrology Dialysis Transplantation 2009 24 12 3694 3701
48. Lv J., Zhang H., Chen Y., Li G., Jiang L., Singh A. K., Wang H., Combination therapy of prednisone and ACE inhibitor versus ACE-inhibitor therapy alone in patients with IgA nephropathy: a randomized controlled trial American Journal of Kidney Diseases 2009 53 1 26 32
49. Eitner F., Floege J., Glomerular disease: ACEIs with or without corticosteroids in IgA nephropathy? Nature Reviews Nephrology 2010 6 5 252 254
50. Pozzi C., Andrulli S., Pani A., Scaini P., Del Vecchio L., Fogazzi G., Vogt B., De Cristofaro V., Allegri L., Cirami L., Procaccini A. D., Locatelli F., Addition of azathioprine to corticosteroids does not benefit patients with IgA nephropathy Journal of the American Society of Nephrology 2010 21 10 1783 1790
51. Tang S. C. W., Tang A. W. C., Wong S. S. H., Leung J. C. K., Ho Y. W., Lai K. N., Long-term study of mycophenolate mofetil treatment in IgA nephropathy Kidney International 2010 77 6 543 549
52. Yoshikawa N., Ito H., Sakai T., Takekoshi Y., Honda M., Awazu M., Ito K., Iitaka K., Koitabashi Y., Yamaoka K., Nakagawa K., Nakamura H., Matsuyama S., Seino Y., Takeda N., Hattori S., Ninomiya M., A controlled trial of combined therapy for newly diagnosed severe childhood IgA nephropathy Journal of the American Society of Nephrology 1999 10 1 101 109 (Pubitemid 29034948)
53. Yoshikawa N., Honda M., Iijima K., Awazu M., Hattori S., Nakanishi K., Ito H., Steroid treatment for severe childhood IgA nephropathy: a randomized, controlled trial Clinical journal of the American Society of Nephrology 2006 1 3 511 517
54. Maes B. D., Oyen R., Claes K., Evenepoel P., Kuypers D., Vanwalleghem J., Van Damme B., Vanrenterghem Y. F. CH., Mycophenolate mofetil in IgA nephropathy: results of a 3-year prospective placebo-controlled randomized study Kidney International 2004 65 5 1842 1849 (Pubitemid 38591034)
55. Frisch G., Lin J., Rosenstock J., Markowitz G., D'Agati V., Radhakrishnan J., Preddie D., Crew J., Valeri A., Appel G. B., Mycophenolate mofetil (MMF) vs placebo in patients with moderately advanced IgA nephropathy: a double-blind randomized controlled trial Nephrology Dialysis Transplantation 2005 20 10 2139 2145 (Pubitemid 41510089)
56. Koselj M., Rott T., Kandus A., Vizjak A., Malovrh M., Donor-transmitted IgA nephropathy: long-term follow-up of kidney donors and recipients Transplantation Proceedings 1997 29 8 A 3406 3407 (Pubitemid 28008527)
57. Silva F. G., Chander P., Pirani C. L., Hardy M. A., Disappearance of glomerular mesangial IgA deposits after renal allograft transplantation. Transplantation 1982 33 2 241 246
58. Novak J., Vu H. L., Novak L., Julian B. A., Mestecky J., Tomana M., Interactions of human mesangial cells with IgA and IgA-containing immune complexes Kidney International 2002 62 2 465 475 (Pubitemid 34779757)
59. Moura I. C., Arcos-Fajardo M., Sadaka C., Leroy V., Benhamou M., Novak J., Vrtovsnik F., Haddad E., Chintalacharuvu K. R., Monteiro R. C., Glycosylation and size of IgA1 are essential for interaction with mesangial transferrin receptor in IgA nephropathy Journal of the American Society of Nephrology 2004 15 3 622 634 (Pubitemid 38294792)
60. Lamm M. E., Emancipator S. N., Robinson J. K., Yamashita M., Fujioka H., Qiu J., Plaut A. G., Microbial IgA protease removes IgA immune complexes from mouse glomeruli in vivo: potential therapy for IgA nephropathy American Journal of Pathology 2008 172 1 31 36 (Pubitemid 351186365)
61. Tanaka M., Seki G., Ishizawa K., Hirahashi J., Miura K., Sekine T., Someya T., Hataya H., Nagata M., Fujita T., Resolution of Henoch-Schnlein purpura nephritis after acquired IgA deficiency Pediatric Nephrology 2010 25 11 2355 2358
62. International Study of Kidney Disease in Children, Nephrotic syndrome in children: prediction of histopathology from clinical and laboratory characteristics at time of diagnosis Kidney International 1978 13 2 159 165
63. Schrer K., Krmar R., Querfeld U., Ruder H., Waldherr R., Schaefer F., Clinical outcome of Schonlein-Henoch purpura nephritis in children Pediatric Nephrology 1999 13 9 816 823